Article Per Year (5 Year)
p-Index From 2020 - 2025
3.11
P-Index
This Author published in this journals
All Journal Jurnal Ekonomi Pembangunan: Kajian Masalah Ekonomi dan Pembangunan Economica: Jurnal Ekonomi Islam AFRE Accounting Financial Review AFEBI Management and Business Review The Management Journal of Binaniaga Economac: Jurnal Ilmiah Ilmu Ekonomi JURNAL MAKRO MANAJEMEN Performance Business Innovation and Entrepreneurship Journal JPEK (Jurnal Pendidikan Ekonomi dan Kewirausahaan) Jurnal EK dan BI Jurnal Ilmiah Manajemen Ubhara Jurnal Kajian Manajemen dan Wirausaha EMBISS: Jurnal Ekonomi, Manajemen, Bisnis, Sosial Jurnal Ekonomi, Bisnis dan Manajemen JURNAL ILMU MANAJEMEN SABURAI (JIMS) Jurnal bintang manajemen Manajemen Kreatif Jurnal Jurnal Kewirausahaan dan Manajemen Bisnis CUAN
Ramdani, Deni
Universitas Tidar
Humanities Decision Sciences, Operations Research & Management Economics, Econometrics & Finance Education Social Sciences Other

Published : 22 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search
Journal : EMBISS: Jurnal Ekonomi, Manajemen, Bisnis, Sosial

 1 
Analisis Pengaruh Return On Equity, Debt to Equity Ratio dan Pertumbuhan Penjualan (Growth) Terhadap Harga Saham Perusahaan Sektor Farmasi Yang Terdaftar Di Bursa Efek Indonesia Periode Tahun 2017-2021 Sholi Robiyatun; Deni Ramdani
JURNAL EKONOMI, MANAJEMEN, BISNIS, DAN SOSIAL (EMBISS) Vol. 3 No. 1 (2022): November 2022
Publisher : CV ODIS

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

The COVID-19 pandemic has resulted in a shift in human lifestyles and increased sensitivity to health. The demand for health products is increasing in response to several policies from the government. The purpose of this study is to determine the effect of the Return on Equity Ratio, Debt to Equity Ratio, and Sales Growth (Growth) on the Stock Prices of Pharmaceutical Sector Companies Listed on the Indonesia Stock Exchange for the 2017-2021 Period. The sample used is all pharmaceutical companies listed on the Indonesia Stock Exchange, then the selection is made using the purposive sampling method. The data analysis technique used is multiple linear analysis using SPSS 25 software. The partial results show that the Return on Equity variable has a positive and significant effect on stock prices. While the other two independent variables, namely Debt to Equity Ratio and growth did not affect stock prices. However, the test results simultaneously show that all independent variables, namely Return on Equity, Debt to Equity Ratio, and Sales growth (Growth) jointly affect the company's stock price.
ANALISIS PERBANDINGAN ROI DAN EVA DALAM MENILAI KINERJA KEUANGAN SEKTOR PHARMACEUTICALS & HEALTH CARE RESEARCH Syavia Alvi Maulidya Arma; Deni Ramdani
JURNAL EKONOMI, MANAJEMEN, BISNIS, DAN SOSIAL (EMBISS) Vol. 3 No. 1 (2022): November 2022
Publisher : CV ODIS

Show Abstract | Download Original | Original Source | Check in Google Scholar

Abstract

This study aims to analyze the comparison of Economic Value Added (EVA) and Return On Investment (ROI) in assessing the performance of the Pharmaceuticals & Health Care Research financial subsector listed on the Indonesia Stock Exchange (IDX). The research was conducted using a descriptive method with a quantitative approach, where the data obtained will be processed and analyzed to draw conclusions. The research was conducted on the analysis of numerical data obtained through financial reports published on the Indonesia Stock Exchange (IDX). The observation period was from 2020-2021. The results showed that the financial performance of the Pharmaceuticals & Health Care Research sub-sector using EVA and ROI analysis showed that PT Kalbe Farma Tbk. (KLBF) is a company with the best economic value creation. Meanwhile, if measured using the analysis of Return On Investment (ROI), the results showed that PT Industri Jamu and Pharmacy Sido Muncul Tbk. (SIDO) as the company with the best investment turnover rate. The results of the overall analysis show that EVA is more appropriate to be used to assess company performance than ROI.
Co-Authors Anang Makruf Asri Khayati Elinda Dwi Kusuma Endang Kartini Fian Dwi Rahayu Fitri Ngumdatul Robikah Hadi Sasana Hana’a Afifah hirawati, heni Indah Ayu Johanda Putri Iswanaji, Chaidir Jalu Aji Prakoso Jihad Lukis Panjawa Mas Eko Affandi Muhammad - Fitrah Muhammad Hasan Absori Novika Rahmatika Novika Rahmatika Novitaningtyas, Ivo Panji Kusumo Prasetyanto Sholeh Nur Rohmat Sholi Robiyatun Suci Nasehati Sunaningsih Supanji Setyawan Syavia Alvi Maulidya Arma Yacobo P. Sijabat Yusnia Paramita